Terminology Service for NFDI4Health
All terms in BAO
| Label | Id | Description |
|---|---|---|
| EC 3.11.1.3 (phosphonopyruvate hydrolase) inhibitor | CHEBI_62609 | |
| EC 3.11.1.* (hydrolases acting on C-P bonds of phosphono-acetaldehyde, -acetate, or -pyruvate) inhibitor | CHEBI_76883 | |
| EC 4.2.1.3 (aconitate hydratase) inhibitor | CHEBI_62608 | |
| EC 4.2.1.* (hydro-lyases) inhibitor | CHEBI_76907 | |
| EC 1.14.16.2 (tyrosine 3-monooxygenase) inhibitor | CHEBI_63932 | |
| EC 1.14.16.* (oxidoreductase acting on paired donors, reduced pteridine as one donor, incorporating 1 atom of oxygen) inhibitor | CHEBI_76847 | |
| pompholyx | DOID_9230 | |
| alpha1B-adrenoceptor antagonist | CHEBI_63936 | |
| cyclooxygenase 2 inhibitor | CHEBI_50629 | |
| EC 3.2.1.1 (alpha-amylase) inhibitor | CHEBI_50627 | |
| central sleep apnea | DOID_9220 | [A sleep apnea that is characterized by a malfunction of the basic neurological controls for breathing rate and the failure to give the signal to inhale, causing the individual to miss one or more cycles of breathing.] |
| sleep apnea | DOID_0050847 | [A sleep disorder characterized by repeated cessation and commencing of breathing that repeatedly disrupts sleep.] |
| EC 2.7.3.2 (creatine kinase) inhibitor | CHEBI_73354 | |
| EC 2.7.3.* (phosphotransferases with a nitrogenous group as acceptor) inhibitor | CHEBI_76818 | |
| protein-sequencing agent | CHEBI_73352 | |
| sclerotherapy agent | CHEBI_63923 | |
| negative regulation of membrane potential | GO_0045837 | [Any process that stops, prevents, or reduces the frequency, rate or extent of establishment or extent of a membrane potential, the electric potential existing across any membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane.] |
| erythromelalgia | DOID_9240 | |
| positive regulation of membrane potential | GO_0045838 | [Any process that activates or increases the frequency, rate or extent of establishment or extent of a membrane potential, the electric potential existing across any membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane.] |
| EC 4.2.1.1 (carbonic anhydrase) inhibitor | CHEBI_23018 |